Iressa Puzzle
Dec. 25, 2024
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review). | Semantic Scholar PPT - IRESSA: A journey of experience from broad to biomarker populations PowerPoint Presentation - ID:311161 PPT - IRESSA: A journey of experience from broad to biomarker populations PowerPoint Presentation - ID:311161 Iressa Puzzle